Management of Mastalgia in Breast Health

Mastalgia encompasses breast pain that can be classified as cyclical or non-cyclical, with a global prevalence that affects up to two thirds of women during their reproductive years. A structured clinical approach begins with a detailed history to characterise pain patterns, alongside examination and judicious use of imaging to exclude red flags such as malignancy. First-line management emphasises patient education, reassurance and lifestyle modification, including exercise, proper support garments and avoidance of caffeine and tobacco. Topical analgesics and non-steroidal anti-inflammatory drugs form the cornerstone of symptomatic relief. For persistent or severe cases, hormonal agents such as selective oestrogen receptor modulators, danazol or oral contraceptives may be deployed, guided by risk-benefit considerations. Complementary therapies, notably evening primrose oil and vitamin E, have gained traction in cyclical mastalgia, while emerging evidence on acupuncture underscores non-pharmacological pathways. Multidisciplinary collaboration between breast specialists, primary care practitioners and mental health professionals addresses the psychosocial dimensions of chronic pain. Advances in service delivery, including telehealth triage models, enhance access and preserve resources for high-risk presentations. This integrative framework promotes personalised treatment algorithms that balance efficacy, tolerability and patient preference.

Research from Nature Portfolio

Recent studies have elucidated key risk factors that modulate mastalgia severity. A large observational analysis has demonstrated that elevated body mass index, increased sternal notch-to-nipple distance indicative of breast ptosis, and lifestyle behaviours such as high tea consumption, smoking and alcohol use, are significantly associated with both the incidence and intensity of breast pain. These findings reinforce the importance of biomechanical and environmental determinants in risk stratification and highlight potential targets for preventive counselling and personalised intervention.

Management of Mastalgia in Breast Health publication trend

The graph below shows the total number of articles in management of mastalgia in breast health across all publications each year (not limited to Nature Index journals).

Technical terms

Mastalgia: Breast pain, either cyclical or non-cyclical in pattern.

Cyclical mastalgia: Pain that fluctuates with the menstrual cycle, most severe in the luteal phase.

Acyclical mastalgia: Breast pain occurring independently of hormonal cycle, often focal or persistent.

Sternal notch-to-nipple distance (SNND): Anthropometric measure used to quantify breast ptosis.

Evening primrose oil: A complementary remedy rich in gamma-linolenic acid evaluated for relief of cyclical breast pain.

References

1. Assessment of prevalence and factors affecting Mastalgia among early reproductive-aged women in Bangladesh: a cross-sectional survey. BMC Public Health (2023).
2. Effects of sagging breasts and other risk factors associated with mastalgia: a case–control study. Scientific Reports (2021).
3. Efficient management of new patient referrals to a breast service: the safe introduction of an advanced nurse practitioner-led telephone breast pain service. Annals of The Royal College of Surgeons of England (2023).
4. Effectiveness of Evening Primrose and Vitamin E for Cyclical Mastalgia: A Prospective Study. Cureus (2024).
5. Effectiveness of acupuncture in the treatment of cyclic mastalgia: a study protocol for a randomized controlled trial. BMC Complementary Medicine and Therapies (2022).